Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹437.85
1.30 (0.30%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹4.63K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
34.3
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹118+271.1%
52W High₹462.8-5.4%
Current Price
₹437.85
Circuit Limits (10%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹394.07
Upper Circuit₹481.64
Reference Price
₹437.85
Investment Checklist
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹237.17
Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹217.0
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
RSI at 72.1 — overbought, pullback risk
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
84%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
388.21
EMA50
327.56
EMA200
231.04
Price Action
MIXED
NEUTRAL
Higher Highs6
Higher Lows5
Lower Highs3
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹462.80
Support (Below)
₹281.00
₹266.25
₹251.00
₹243.90
₹232.00
Volume Analysis
TrendDECREASING
Change-69.30%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹433.47
3% Risk₹424.71
5% Risk₹415.96
7% Risk (Custom)
₹407.20Technical Levels
1x ATR (Volatility)₹416.37
2x ATR (Swing)₹394.89
3x ATR (Trend)₹373.41
Immediate Support₹281.00
Moving Averages
EMA 9 (Short-term)₹423.11
EMA 20 (Medium-term)₹388.21
EMA 50 (Trend)₹327.56
EMA 200 (Long-term)₹231.04
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹190.1 Cr | ₹207.5 Cr | ₹244.4 Cr | ₹218.3 Cr |
| Net Profit | ₹15.5 Cr | ₹43 Cr | ₹27.3 Cr | ₹23.3 Cr |
| EPS | — | ₹4.08 | ₹2.58 | ₹2.20 |
| Operating Profit | ₹31.2 Cr | ₹76.8 Cr | ₹51.9 Cr | ₹50.7 Cr |
ROE
8.03%
ROCE
11.58%
Debt/Equity
0.08
Current Ratio
4.81
OPM
23.24%
NPM
10.66%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 18 Feb 2026 | Interim Dividend - Re 0.50 Per Share | INTERIM_DIVIDEND |
| 24 Jul 2025 | Annual General Meeting/Dividend - Rs 0.50 Per Share | AGM |
| 18 Jul 2024 | Annual General Meeting/Dividend - Rs 0.50 Per Share | AGM |
| 12 Jul 2023 | Annual General Meeting/Dividend - Re 0.50 Per Share | AGM |
| 20 Jun 2022 | Annual General Meeting/ Dividend - Rs 0.50 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for BLISSGVS
View AllNEWS
positive
Business Standard - Markets 10d ago
CRISIL places Anupam Rasayan's credit ratings on watch
The ratings have been placed on watch following announcement by ARIL of acquisition of 43.3-48.2% equity stake in Bliss GVS Pharma, a pharmaceutical (pharma) formulations company based in India, which may be funded through debt, equity or internal accrual.
ABGSECANURASBLISSGVSCRISILChemicalsFinancial Services
positive
CNBC TV18 - Markets 10d ago
Here's why Bliss GVS Pharma shares have surged over 45% over the last 10 sessions
Bliss GVS Pharma shares have surged over 45% since the time it announced its deal with Anupam Rasayan. The WHO update is another positive news from the stock.
ANURASBLISSGVSChemicalsHealthcare
NEWS
positive
Business Standard - Markets 18d ago
Modison Ltd leads gainers in 'B' group
Hitech Corporation Ltd, Bliss GVS Pharma Ltd, Biofil Chemicals & Pharmaceuticals Ltd and Indo Rama Synthetics (India) Ltd are among the other gainers in the BSE's 'B' group today, 26 May 2026.
BIOFILCHEMBLISSGVSBSEHITECHHITECHCORPINDOBORAXINDORAMAIOLCPJBCHEPHARMJGCHEMMODISONLTDCapital GoodsChemicals